Evidence map›Paper›PMID 30877411›Full record

ReviewThe international journal of cardiovascular imaging2019

Endovascular therapy for acute severe pulmonary embolism.

Qasim A Javed, Akhilesh K Sista

Abstract readReview
PubMed Publisher
In one paragraph

Review in The international journal of cardiovascular imaging, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Acute pulmonary embolism multimodality imaging prior to endovascular therapy.The international journal of cardiovascular imaging · 2021
    Review
  7. Topical issue: advanced imaging and endovascular treatment in pulmonary artery diseases.The international journal of cardiovascular imaging · 2019
    Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Qasim A JavedNYU Langone Health, New York, USA. qasim.javed@nyumc.org.
Akhilesh K SistaNYU Langone Health, New York, USA.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Acute pulmonary embolism (PE) is a major public health problem and accounts for 100,000-180,000 deaths per year in the United States. Current prognostic stratification separates acute PE into massive, submassive, and low-risk by the presence or absence of sustained hypotension, RV dysfunction, and myocardial necrosis. Massive, submassive and low-risk PE have mortality rates of 25-65%, 3%, and < 1%, respectively. In this review we will focus on therapies currently available to manage acute massive and submassive PE.

Indexed as

EmbolectomyThrombolytic TherapyAcute DiseaseCatheterization, Swan-GanzComputed Tomography AngiographyEndovascular ProceduresHemodynamicsHumansPulmonary ArteryPulmonary CirculationPulmonary EmbolismRisk AssessmentRisk FactorsSeverity of Illness IndexTreatment OutcomeCatheter-directed therapyCatheterdirected thrombolysisEmbolectomyMassive pulmonary embolismPulmonary embolismSubmassive pulmonary embolismThrombolysisVenous thromboembolic disease

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.